Le Lézard
Classified in: Health

Gousse Urology Expands to West Palm Beach


WEST PALM BEACH, Fla., Jan. 16, 2021 /PRNewswire-PRWeb/ -- Gousse Urology, a South Florida urology clinic, is opening a new clinic in West Palm Beach to serve the growing number of patients in the area. When someone has erectile dysfunction, urinary incontinence, or needs a urethral reconstruction, the doctors at Gousse Urology are ready and willing to help.

Gousse Urology clinics has been operating in Miramar and Miami for years. Their medical staff have been helping people through major urologic transformations and treatments. Individuals with an artificial urinary or sphincter implant require special assistance from trained experts, and Gousse Urology has the most experienced urology experts in South Florida.

Gousse Urology offers male and female urology services.
Services for male patients include:

Gousse Urology also offers state-of-the-art medical treatments for a wide variety of female urology problems including recurrent UTIs, overactive bladder, pelvic organ prolapse, urinary fistula, urinary incontinence, interstitial cystitis, urethral diverticula, female sexual dysfunction, and female urethra stricture.

About Dr. Angelo Gousse
The heart of Gousse Urology is Dr. Angelo Gousse, a premier bladder health physician and one of Florida's most renowned reconstructive urologists. He has paved the way for the clinic's continued medical successes. He founded the Bladder Health & Reconstructive Urology Institute and revolutionized treatment of overactive bladder by pioneering the use of Botox and Axonics Sacral Nerve Modulation.

Dr. Gousse earned his Bachelor's degree at York College, City University of New York in Queens, New York. He obtained his medical doctorate with a Magna Cum Laude at the Yale School of Medicine in New Haven. Dr. Gousse obtained a postdoctoral fellowship at UCLA in urodynamics, female urology, and pelvic-floor reconstruction.

He has published over 70 articles in reputable urology research journals and is an editor of many scientific urologic journals. Dr. Gousse currently serves as the director of female pelvic medicine and reconstructive urology at Memorial Hospital Miramar. He continues to assist male and female patients with their urology issues and increasing their quality of life.

Gousse Urology West Palm Beach Office
321 15th Street, Suite 100
West Palm Beach, FL 33401
Phone: (561) 461-8001
Website: https://gousseurology.com/

Media Contact

Angelo Gousse, Gousse Urology, +1 (305) 842-3555, webmaster@gousseurology.com

Facebook

 

SOURCE Gousse Urology


These press releases may also interest you

at 03:22
Yiling Pharmaceutical's business income in 2020 hits 8.736 billion yuan (USD 1.35 billion) with an increase of 49.97% YoY, and the net profit reaches 1.220 billion yuan (USD 189 million), 101.12% YoY growth, according to the Annual Performance...

at 03:00
No one epitomizes the cool use of logic like Sherlock Holmes, who sliced through ignorance and ambiguity with his sharp, precise intellect. "Sentiment," he once remarked, "is a chemical defect found on the losing side." Emotions are often viewed as...

26 fév 2021
The LaunchPorttm announced today that Novel Microdevices (http://www.noveldx.com) has moved to their Medtech venture center in Port Covington, Baltimore, and has established The LaunchPorttm as its primary location for their GMP development efforts....

26 fév 2021
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that the Board of Directors has granted 1,048,000 stock options to certain directors, officers, employees and consultants in...

26 fév 2021
ChenMed, a leading provider of primary care for underserved seniors, is pledging $100,000 in 2021 to address issues affecting communities of color. The philanthropic commitment is part of the company's continued efforts focused on cultural diversity,...

26 fév 2021
Following today's positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an...



News published on 16 january 2021 at 14:00 and distributed by: